» Articles » PMID: 34254992

Medicare and the Shocking US Food and Drug Administration Approval of Aducanumab: Crisis or Opportunity?

Overview
Journal JAMA Intern Med
Specialty General Medicine
Date 2021 Jul 13
PMID 34254992
Citations 15
Authors
Affiliations
Soon will be listed here.
Citing Articles

Differences in setting of initial dementia diagnosis among fee-for-service Medicare beneficiaries.

White E, Bayer T, Kosar C, Santostefano C, Muench U, Oh H J Am Geriatr Soc. 2024; 73(1):39-49.

PMID: 39434608 PMC: 11735312. DOI: 10.1111/jgs.19236.


Graves disease is associated with increased risk of clinical Alzheimer's disease: evidence from the Medicare system.

Yashkin A, Kolpakov S, Ukraintseva S, Yashin A, Akushevich I Clin Diabetes Endocrinol. 2024; 10(1):11.

PMID: 38317215 PMC: 10840251. DOI: 10.1186/s40842-024-00170-z.


Graves Disease is Associated with Increased Risk of Clinical Alzheimer's Disease: Evidence from the Medicare System.

Yashkin A, Kolpakov S, Ukraintseva S, Yashin A, Akushevich I Res Sq. 2023; .

PMID: 37886578 PMC: 10602068. DOI: 10.21203/rs.3.rs-2596630/v1.


Association of Arts Event Attendance With Cognitive Function Among Older Adults Enrolled in the Health and Retirement Study.

Ike J, Choi H, Cho T, Howell J, Langa K Innov Aging. 2023; 7(3):igad015.

PMID: 37033408 PMC: 10079814. DOI: 10.1093/geroni/igad015.


Manipulation of the diet-microbiota-brain axis in Alzheimer's disease.

Lee D, Lee V, Hur S Front Neurosci. 2022; 16:1042865.

PMID: 36408394 PMC: 9672822. DOI: 10.3389/fnins.2022.1042865.